Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $28.7500 (-1.3%) ($28.5500 - $29.7600) on Tue. Oct. 6, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.1% (three month average) | RSI | 33 | Latest Price | $28.7500(-1.3%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.2% a day on average for past five trading days. | Weekly Trend | EDIT declines -7.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(61%) IWO(57%) ARKG(55%) IWC(54%) IBUY(53%) | Factors Impacting EDIT price | EDIT will decline at least -2.05% in a week (0% probabilities). VIXM(-28%) UUP(-14%) VXX(-12%) TBT(-7%) EDOC(-7%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -2.05% (StdDev 4.1%) | Hourly BBV | 0.5 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $16.85(-41.39%) | Resistance Level | $30.36 | 5 Day Moving Average | $28.24(1.81%) | 10 Day Moving Average | $28.89(-0.48%) | 20 Day Moving Average | $30.36(-5.3%) | To recent high | -22.6% | To recent low | 6.1% | Market Cap | $1.785b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |